Abiopharma

Douglas Emmett Declares Quarterly Cash Dividend

SLB e Vår Energi expandem cooperação digital para ampliar o planejamento integrado de desenvolvimento de poços e campos

Johnson & Johnson - FDA approves label expansion, cementingTREMFYA® as the only IL‑23 inhibitor proven to help stop further joint damage

Essential Performance and Real-time Control Without the Baggage

FDA approves label expansion, cementing TREMFYA® as the only IL‑23 inhibitor proven to help stop further joint damage

SLB e Vår Energi ampliano la collaborazione digitale per ridimensionare la pianificazione dello sviluppo integrato di pozzi e giacimenti

Pfizer Inc. - Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

SLB und Vår Energi weiten ihre digitale Zusammenarbeit aus, um die Bohrloch- und integrierte Feldentwicklungsplanung zu optimieren

CTEV INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Claritev Corporation

INVESTOR ALERT: Securities Class Action Filed Against Calix, Inc. – Investors Encouraged to Contact Kirby McInerney LLP